Jenni Björnulfson
Algemeen Directeur bij LIDDS AB
Actieve functies van Jenni Björnulfson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
GHP SPECIALTY CARE AB (PUBL) | Corporate Officer/Principal | - | - |
LIDDS AB | Algemeen Directeur | 01-12-2023 | - |
Financieel Directeur/CFO | 01-12-2021 | - | |
Investor Relations Contact | 01-12-2021 | - | |
The C Story AB | Directeur/Bestuurslid | - | - |
Cinclus Pharma Holding AB
Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021. | Financieel Directeur/CFO | - | - |
Loopbaan van Jenni Björnulfson
Eerdere bekende functies van Jenni Björnulfson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Promore Pharma AB
Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | Financieel Directeur/CFO | 01-01-2016 | 25-08-2020 |
Investor Relations Contact | 01-01-2016 | 25-08-2020 | |
BIO VITOS PHARMA AB | Directeur/Bestuurslid | 01-01-2016 | - |
Independent Dir/Board Member | 01-01-2016 | - |
Opleiding van Jenni Björnulfson
Stockholm School of Economics | Graduate Degree |
Karolinska Institutet | Undergraduate Degree |
Statistieken
Internationaal
Zweden | 9 |
Operationeel
Director of Finance/CFO | 3 |
Director/Board Member | 2 |
Investor Relations Contact | 2 |
Sectoraal
Health Technology | 5 |
Consumer Services | 3 |
Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
BIO VITOS PHARMA AB | Health Technology |
LIDDS AB | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Promore Pharma AB
Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | Health Technology |
GHP Specialty Care AB
GHP Specialty Care AB Medical/Nursing ServicesHealth Services GHP Specialty Care AB engages in the provision of healthcare services. It operates business through the Nordic Region and Rest of the World segments. The Nordic Region segment conducts business within specialist care, such as spine surgery/spine care, orthopaedics, obesity surgery and diabetes care, gastroenterology, urology, gynaecology, general surgery, arrhythmia, maternal health care, plastic surgery, and specialist dentistry. The Rest of the World segment manages business in the field of diabetes care at one clinic in the United Arab Emirates. The company was founded by Per Båtelson and Johan Wachtmeister in 2006 and is headquartered in Göteborg, Sweden. | Health Services |
The C Story AB | |
Cinclus Pharma Holding AB
Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021. | Health Technology |
- Beurs
- Insiders
- Jenni Björnulfson
- Ervaring